Why Ulcerative Colitis Was the Only Use Evaluated FDA narrowed the review to the supported nomination The agency evaluated BPC-157 free base and acetate for ulcerative colitis because that was the use for which it determined there was enough nomination information to conduct the committee review
Anita Petruzzelli, a dual board-certified OB-GYN and integrative medicine physician, combines advanced medical science with personalized, patient-focused strategies to deliver comprehensive care
Author contributions SE: Conceptualization, Formal Analysis, Investigation, Methodology, Validation, Visualization, Writing original draft, Writing review & editing
A personalized evaluation helps determine whether symptoms may be related to hormonal changes and whether hormone replacement therapy should be considered
Early detection makes treatment much more effective
doi: 10.1001/jama.2015.1346 2 S